Time Warner Inc (TWX) and Twenty-First Century Fox Inc (FOX): Gabelli Is Bullish On Content

Mario Gabelli, the chairman and CEO of GAMCO Investors, has only good words about Time Warner Inc (NYSE:TWX) and Twenty-First Century Fox Inc (NASDAQ:FOX), even if the takeover deal between the two has not materialized. In a video segment on CNBC, the asset manager has said that both companies are on track to bring excellent shareholder value over the next five years, with the stock doubling its price. According to Gabelli, Time Warner Inc (NYSE:TWX), which currently trades at around $72 per share, will be worth $130 per share, while Twenty-First Century Fox Inc (NASDAQ:FOX) stock will jump to $65, from the current price of $33-a-share, in the next five years.

“I think the investors will do quite well owning both,” said Gabelli.

Mario Gabelli

GAMCO Investors, the value hedge fund Gabelli founded in 1986, owns 11 million shares of Twenty-First Century Fox and 2.5 million shares in Time Warner Inc (NYSE:TWX).  The dollar value of Twenty-First Century Fox Inc (NASDAQ:FOX) stake is $363 million, which is almost double compared to the Time Warner Inc (NYSE:TWX) stake of $177 million.

Gabelli indicated that he is more bullish on Twenty-First Century Fox Inc (NASDAQ:FOX), which may have brighter prospects.

Twenty-First Century Fox Inc (NASDAQ:FOX) has put forward and then removed a proposal to buy Time Warner Inc (NYSE:TWX) for $80 billion, following the target board’s refusal to discuss the deal. Gabelli has said that he is “neutral” on the acquisition, indicating, however, that a raise of the bid to $100 per share would have been too much. If it were to happen, the deal could have brought additional value to shareholders through synergies, suggested Gabelli.

“[...] The vision of the future is simple. [...] The rising middle-class in India and China, and you go anywhere in the world and you see, they go with the smartphones, the mobility, they want content, and having both [companies] put together with the right synergies,” could have made the merger work, said Gabelli.

Disclosure: None

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!